Delivery Order SPE2DB22D2206-SPE2DB25FFJ33

Award Date 1/30/25
Potential Completion Date 2/21/25
Potential Value $8.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the drug TIVDAK 40 MG VIALS. The firm-fixed-price delivery order has a ceiling value of $11,956.29 and an ultimate completion date of December 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product TIVDAK 40 MG VIALS to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 22, 2024 and a ceiling value of $23,912.58. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $1,526.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TDVAX VIAL 0.5ML medical supplies, with an ultimate completion date of September 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $6,715.01 Delivery Order contract is for the supply of TALVEY 40 MG/ML VIALML, a specific pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 7, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,430.02, is for the delivery of a pharmaceutical product called TALVEY 40 MG/ML VIALML. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,994.80 firm fixed price delivery order is for the supply of 4563968987 TDVAX VIAL 0.5ML pharmaceutical products. This award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.07 firm fixed-price delivery order is for the supply of 4566120553 TALVEY 3 MG/1.5 ML VIAL 1.5ML, with a completion date of November 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is a Delivery Order valued at $26,371.20 for pharmaceutical vials. The contract has a completion date of May 17, 2023 and is a Firm Fixed Price agreement. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,610.62, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, which runs through November 2026 and has a ceiling value of $999,999,999. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,023.08 firm-fixed-price delivery order contract has a completion date of December 17, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFJ33
    Delivery Order

This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FFJ33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TIVDAK 40 MG VIALS. The contract has a ceiling value of $8,722.50 and is a Firm Fixed Price Delivery Order, with a period of performance ending on February 21, 2025. This award is not associated with a set-aside designation.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/4/25, 12:53 AM